Blackstone Inc
JBIO

Blackstone Inc’s Jade Biosciences JBIO Stock Holding History

Blackstone Inc’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.67M Buy
+435,320
New +$9.08M 0.03% 101
2025
Q2 		– Sell
-27,289
Closed -$2.4M – 175
2025
Q1 		$2.4M Buy
27,289
+13,016
+91% +$1.14M 0.01% 111
2024
Q4 		$1.32M Buy
+14,273
New +$1.23M 0.01% 120

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Blackstone Inc's JBIO Position: Q2 2026 in Review

Blackstone Inc opened a new position in Jade Biosciences (JBIO) in Q2 2026: 435,320 shares worth $9.67M. The stake represents 0.03% of the portfolio and ranks #101 among its holdings. This is a return to the name: Blackstone Inc previously reported a position in JBIO as recently as Q1 2025.

Blackstone Inc first reported a position in JBIO in Q4 2024 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Blackstone Inc held 435,320 shares of Jade Biosciences worth $9.67M as of Q2 2026.
  • Jade Biosciences was a new Blackstone Inc position in Q2 2026.
  • Jade Biosciences made up 0.03% of Blackstone Inc's portfolio in Q2 2026, its #101 holding.
  • Blackstone Inc first reported a position in Jade Biosciences in Q4 2024 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.